Efficacy of Adjuvant Tamsulosin for Improving the Stone-Free Rate after Extracorporeal Shock Wave Lithotripsy in Renal Stones: A Randomized Controlled Trial.

Rafael Edgardo Maldonado-Valadez Angel David Valdez-Vargas José Antonio Alvarez Edel Rafael Rodea-Montero

Published in: International journal of clinical practice (2022)

Our findings suggest that tamsulosin as adjuvant treatment after a single ESWL session is well tolerated and safe, but it does not increase the stone-free rate in patients with a single radiopaque renal stone of 5-20 mm in diameter. Our results may support the use of tamsulosin with ESWL in the case of patients with a single radiopaque renal stone of 11-20 mm in diameter based on an apparent higher stone-free rate and a low rate of complications.

Keyphrases

benign prostatic hyperplasia
lower urinary tract symptoms
editorial comment
risk factors
computed tomography